Source: https://www.robinskaplan.com/resources/newsletters/generically-speaking-hatch-waxman-bulletin/generically-speaking-winter-2011-2012
Timestamp: 2019-04-25 02:57:18+00:00

Document:
The Hatch-Waxman Litigation practice group at Robins Kaplan LLP is pleased to offer the latest edition of their quarterly publication concerning ANDA patent litigation issues and the generics business, GENERICally Speaking: A Hatch-Waxman Litigation Bulletin.
This bulletin provides you and your company with some of the knowledge you need to remain attentive to the complexity of ANDA patent litigation. We hope you find it helpful.
Momenta Pharms., Inc. v. Amphastar Pharms, Inc.
Apotex, Inc. v. Cephalon, Inc.
Sciele Pharma, Inc. v. Lupin Ltd.
Alcon Research Ltd. v. Barr Labs. Inc.
Senju Pharm. Co. Ltd. v. Apotex Inc.
Seattle Children’s Hospital v. Akorn, Inc.
Reckitt Benckiser Inc., v. Tris Pharma, Inc.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.